E.i. Dupont De Nemours and Company

Siemens Healthcare Diagnostics Gmbh

Dade Behring Inc.

Alan Robert Craig

Tie Q Wei

Zhu Teng

James E Davis

Carsten Schelp

Amy Posey

Chengrong X Wang

Catharine E Looney

William A Frey

Michael A Luddy

James David Hamerslag

Alan M Hochberg

Jeffrey L Moore

Steve Kramer

Steven J Zoha

Ashok Koul

Charles C Leflar

Gary Hickey

Michael Patrick Reidy

John Carl Steichen

Victor P Chu

Thomas P Hartz, Jr

Jason Snyder

Christine Moran

Richard C Wright

Eileen G Gorman

Tie Quan Wei

Chengrong Wang

Methods and reagents are disclosed for pretreating a sample suspected of containing a hydrophobic drug for conducting an assay method for detecting the hydrophobic drug. A combination is provided in a medium that includes the sample, a releasing agent for releasing the hydrophobic drug and the metabolites from endogenous binding moieties, and a selective solubility agent that provides for substantially equal solubility of the hydrophobic drug and the metabolites in the medium. The selective solubility agent includes a water miscible, non-volatile organic solvent and is present in the medium in a concentration sufficient to provide for substantially equal solubility of the hydrophobic drug and the metabolites in the medium. The medium, which may further include a hemolytic agent, is incubated under conditions for releasing the hydrophobic drug and the metabolites from endogenous binding moieties. The pretreated sample may be subjected to an assay for determining the hydrophobic drug.

Methods for detection of hydrophobic drugs

Methods and reagents are disclosed for conducting assays. Embodiments of the present methods and reagents are concerned with a solid support such as, for example, a particle. The support includes a chemiluminescent composition that includes a metal chelate. The present inventors observed that, when such support such as, e.g., particles, were employed in assays for the determination of an analyte, stability of signal output by the chemiluminescent composition associated with the particle was unacceptably reduced as compared to particles including other chemiluminescent compositions. In accordance with embodiments of the present invention, the stability of signal output from such particles is enhanced by including in a medium that contains the particles a sufficient amount of one or more stabilizing agents, which may be a chelating agent and/or a metal chelate such as, for example, the metal chelate that is associated with the particle.

Stabilization of signal generation in particles used in assays

Methods and reagents are disclosed for pretreating a sample suspected of containing a hydrophobic drug for conducting an assay method for detecting the hydrophobic drug. A combination is provided in a medium. The combination comprises (i) the sample, (ii) a releasing agent for releasing the hydrophobic drug and the metabolites from endogenous binding moieties, and (iii) a selective solubility agent that provides for substantially equal solubility of the hydrophobic drug and the metabolites in the medium. The selective solubility agent comprises a water miscible, non-volatile organic solvent and is present in the medium in a concentration sufficient to provide for substantially equal solubility of the hydrophobic drug and the metabolites in the medium. The medium, which may further comprise a hemolytic agent, is incubated under conditions for releasing the hydrophobic drug and the metabolites from endogenous binding moieties. For conducting an assay for the hydrophobic drug, the above pretreatment is performed and to the medium is added reagents for determining the presence and/or amount of the hydrophobic drug in the sample wherein the reagents comprise at least one antibody for the hydrophobic drug. The medium is examined for the presence of a complex comprising the hydrophobic drug and the antibody for the hydrophobic drug, the presence and/or amount of the complex indicating the presence and/or amount of the hydrophobic drug in the sample.

In some embodiments, the present invention pertains to a method for conjugating a first compound to a second compound wherein the conjugation involves an electrophilic moiety. The method comprises reacting the first compound with the second compound to form a conjugate. The improvement in embodiments of the present invention comprises adding a nucleophilic reagent to the conjugate wherein the nucleophilic reagent forms a neutral product upon reaction with unreacted electrophilic moieties of the conjugate. In some embodiments, the nucleophilic reagent is substantially non-reactive with disulfide bonds in the event that the conjugate comprises disulfide bonds. The conjugate formed is doubly deactivated because the other moiety for linking to the electrophilic moiety is also deactivated.

Deactivation of linking moieties in antibody-enzyme conjugates

Compositions suitable for use as signal generation components of an immunoassay, and methods for their use. According to one aspect of the invention, the composition includes a carrier having a coating of an aminodextran and a metal chelate incorporated therein. The metal chelate is present in the amount of at least 0.065 &#x3bc;Mole per gram of carrier, and the aminodextran coating density averaging at least about 45 &#x3bc;g per milligram of carrier. In another aspect of the invention, carrier is dyed with a complex having the formula:M(L1)(L2), wherein R is one or more substituents, each substituent comprising an electron donating group; n=2-10; x=1-2; and y=2-4.

Compositions for use as a signal generation component and methods of using same

Methods and compositions are disclosed for reducing non-specific binding in a binding assay for the determination of an analyte in a sample where one of the reagents for conducting the binding assay comprises a solid support comprising a polysaccharide. The method comprises including in an assay medium for conducting the binding assay a soluble compound comprising a protein linked to a polysaccharide. Also disclosed are methods and compositions for determining the presence and/or amount of an analyte in a sample suspected of containing the analyte. The methods include as reagents a solid support comprising a polysaccharide and a soluble compound comprising a protein linked to a polysaccharide.

Reduction of non-specific binding in assays

A method for extending the uselife of a chloride ion selective membrane of an ISE sensor by providing a two-layer sensor structure wherein an quaternized ion-selective polymeric layer is positioned between a sample to be analyzed and a conventional polymeric ISE membrane containing an ion-exchange agent. Also provided are polymer compositions comprised methyl methacrylate/choloromethyl styrene copolymer and mixtures thereof that have been reacted with tertiary amines.

Chloride ion selective membrane electrode having improved stability and

This invention pertains to fluorophoric compositions and methods of their use for enhancing visualization of various constituents of ion selective electrodes.

Composition and method for manufacturing ion selective electrode sensors

A method for extending the uselife of a sodium ion selective membrane of an ISE sensor by incorporating water therein. Also provided are polymer compositions comprised of water plus the membrane compounds or residues and articles comprising such compositions.

Sodium ion-selective-electrode membrane having extended uselife

This invention pertains to fluorophoric compositions of a 7-amino-coumarin derivative and methods of their use for enhancing visualization of various constituents of ion selective electrodes.

A method is provided for enhancing the stability and increasing the activity of polymer particle reagents by incubating a polymer particle which has been covalently bound to a compound of biological interest, such as a drug, with a modifying agent that will place a negative charge on the surface of the polymer particle and reduce residual functional groups. The modifying agent is preferably an anionic nucleophile selected from the group consisting of .beta.- mercaptoacetic acid and the thiosulfates.

Post synthesis chemical modification of particle reagents

This invention relates to novel quaternary ammonium immunogenic conjugates and reporter reagents useful for eliciting antibodies and in immunoassays. Processes for preparing such quaternary ammonium immunogenic conjugates and their use in immunoassays and in eliciting antibodies are also disclosed.

Growing community of inventors

Wilmington, DE, United States of America

Alan Robert Craig